A Gene Gravity Model for the Evolution of Cancer Genomes: A Study of 3,000 Cancer Genomes across 9 Cancer Types

PLoS Computational Biology

Volumn 11, Issue 9, 2015, Pages

  Cheng, Feixiong ^a   Liu, Chuang ^b   Lin, Chen Ching ^a   Zhao, Junfei ^a   Jia, Peilin ^a,c   Li, Wen Hsiung ^d,e   Zhao, Zhongming ^a,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HANGZHOU NORMAL UNIVERSITY   (China)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e BIODIVERSITY RESEARCH CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROLIFERATION; DISEASES; TRANSCRIPTION;

ANGIOGENESIS; CANCER DEVELOPMENT; CANCER GENOME; CANCER PROGRESSION; EVOLUTIONARY ADAPTATION; GENOME EVOLUTION; GENOMIC ALTERATIONS; GRAVITY MODELING; SOMATIC CELLS; SOMATIC MUTATION;

TUMORS;

ARTICLE; CANCER GENETICS; CARCINOGENESIS; COL11A1 GENE; CONTROLLED STUDY; DDX3X GENE; EPIGENETICS; FAT4 GENE; GENE GRAVITY MODEL; GENE MUTATION; GENETIC MODEL; MOLECULAR EVOLUTION; QUANTITATIVE ANALYSIS; SOMATIC MUTATION; STAG2 GENE; SYNE1 GENE; TUMOR GENE; WILD TYPE; X CHROMOSOME; BIOLOGICAL MODEL; FEMALE; GENETIC DATABASE; GENETICS; GENOMICS; HUMAN; HUMAN GENOME; MALE; MUTATION; NEOPLASM; PROCEDURES;

DATABASES, GENETIC; FEMALE; GENOME, HUMAN; GENOMICS; HUMANS; MALE; MODELS, GENETIC; MUTATION; NEOPLASMS;

EID: 84943560509     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1004497     Document Type: Article

References (73)

1. Rahman N, (2014) Realizing the promise of cancer predisposition genes. Nature 505: 302–308. doi: 10.1038/nature12981 24429628
2. Podlaha O, Riester M, De S, Michor F, (2012) Evolution of the cancer genome. Trends Genet 28: 155–163. doi: 10.1016/j.tig.2012.01.003 22342180
3. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Jr.et al. (2013) Cancer genome landscapes. Science 339: 1546–1558. doi: 10.1126/science.1235122 23539594
4. Nowell PC, (1976) The clonal evolution of tumor cell populations. Science 194: 23–28. 959840
5. Greaves M, (2007) Darwinian medicine: a case for cancer. Nat Rev Cancer 7: 213–221. 17301845
6. Imai K, Yamamoto H, (2008) Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics. Carcinogenesis 29: 673–680. 17942460
7. Michor F, (2005) Chromosomal instability and human cancer. Philos Trans R Soc Lond B Biol Sci 360: 631–635. 15897185
8. Teng X, Dayhoff-Brannigan M, Cheng WC, Gilbert CE, Sing CN, et al. (2013) Genome-wide Consequences of Deleting Any Single Gene. Mol Cell 52: 485–494. doi: 10.1016/j.molcel.2013.09.026 24211263
9. Lengauer C, Kinzler KW, Vogelstein B, (1998) Genetic instabilities in human cancers. Nature 396: 643–649. 9872311
10. Negrini S, Gorgoulis VG, Halazonetis TD, (2010) Genomic instability—an evolving hallmark of cancer. Nat Rev Mol Cell Biol 11: 220–228. doi: 10.1038/nrm2858 20177397
11. Emerling BM, Hurov JB, Poulogiannis G, Tsukazawa KS, Choo-Wing R, et al. (2013) Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumors. Cell 155: 844–857. doi: 10.1016/j.cell.2013.09.057 24209622
12. Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SAJR, Behjati S, et al. (2013) Signatures of mutational processes in human cancer. Nature 500: 415–422. doi: 10.1038/nature12477 23945592
13. Liu Y, Zhang X, Han C, Wan G, Huang X, et al. (2015) TP53 loss creates therapeutic vulnerability in colorectal cancer. Nature 520: 697–701. doi: 10.1038/nature14418 25901683
14. Davoli T, Xu AW, Mengwasser KE, Sack LM, Yoon JC, et al. (2013) Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome. Cell 155: 948–962. doi: 10.1016/j.cell.2013.10.011 24183448
15. Pe'er D, Hacohen N, (2011) Principles and strategies for developing network models in cancer. Cell 144: 864–873. doi: 10.1016/j.cell.2011.03.001 21414479
16. Huang S, Ernberg I, Kauffman S, (2009) Cancer attractors: a systems view of tumors from a gene network dynamics and developmental perspective. Semin Cell Dev Biol 20: 869–876. doi: 10.1016/j.semcdb.2009.07.003 19595782
17. Zhong Q, Simonis N, Li QR, Charloteaux B, Heuze F, et al. (2009) Edgetic perturbation models of human inherited disorders. Mol Syst Biol 5: 321. doi: 10.1038/msb.2009.80 19888216
18. Jia P, Wang Q, Chen Q, Hutchinson KE, Pao W, et al. (2014) MSEA: detection and quantification of mutation hotspots through mutation set enrichment analysis. Genome Biol 15: 489. 25348067
19. Mitra K, Carvunis AR, Ramesh SK, Ideker T, (2013) Integrative approaches for finding modular structure in biological networks. Nat Rev Genet 14: 719–732. doi: 10.1038/nrg3552 24045689
20. Kumar S, Dudley JT, Filipski A, Liu L, (2011) Phylomedicine: an evolutionary telescope to explore and diagnose the universe of disease mutations. Trends Genet 27: 377–386. doi: 10.1016/j.tig.2011.06.004 21764165
21. Kumar S, Sanderford M, Gray VE, Ye J, Liu L, (2012) Evolutionary diagnosis method for variants in personal exomes. Nat Methods 9: 855–856. doi: 10.1038/nmeth.2147 22936163
22. Cheng F, Zhao J, Zhao Z, (2015) Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes. Brief Bioinform, in press. doi: 10.1093/bib/bbv068
23. Cheng F, Jia P, Wang Q, Lin CC, Li WH, et al. (2014) Studying tumorigenesis through network evolution and somatic mutational perturbations in the cancer interactome. Mol Biol Evol 31: 2156–2169. doi: 10.1093/molbev/msu167 24881052
24. Papamichos-Chronakis M, Peterson CL, (2013) Chromatin and the genome integrity network. Nat Rev Genet 14: 62–75. doi: 10.1038/nrg3345 23247436
25. Wood RD, Mitchell M, Sgouros J, Lindahl T, (2001) Human DNA repair genes. Science 291: 1284–1289. 11181991
26. Milanowska K, Krwawicz J, Papaj G, Kosinski J, Poleszak K, et al. (2011) REPAIRtoire—a database of DNA repair pathways. Nucleic Acids Res 39: D788–792. doi: 10.1093/nar/gkq1087 21051355
27. Gonzalez-Perez A, Jene-Sanz A, Lopez-Bigas N, (2013) The mutational landscape of chromatin regulatory factors across 4,623 tumor samples. Genome Biol 14: r106. 24063517
28. Tamborero D, Gonzalez-Perez A, Perez-Llamas C, Deu-Pons J, Kandoth C, et al. (2013) Comprehensive identification of mutational cancer driver genes across 12 tumor types. Sci Rep 3: 2650. doi: 10.1038/srep02650 24084849
29. Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, et al. (2013) Mutational landscape and significance across 12 major cancer types. Nature 502: 333–339. doi: 10.1038/nature12634 24132290
30. Lawrence MS, Stojanov P, Mermel CH, Robinson JT, Garraway LA, et al. (2014) Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505: 495–501. doi: 10.1038/nature12912 24390350
31. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, et al. (2004) A census of human cancer genes. Nat Rev Cancer 4: 177–183. 14993899
32. Jia P, Zhao Z, (2014) VarWalker: personalized mutation network analysis of putative cancer genes from next-generation sequencing data. PLoS Comput Biol 10: e1003460. doi: 10.1371/journal.pcbi.1003460 24516372
33. Govindan R, Ding L, Griffith M, Subramanian J, Dees ND, et al. (2012) Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell 150: 1121–1134. doi: 10.1016/j.cell.2012.08.024 22980976
34. Wang ZC, Birkbak NJ, Culhane AC, Drapkin R, Fatima A, et al. (2012) Profiles of genomic instability in high-grade serous ovarian cancer predict treatment outcome. Clin Cancer Res 18: 5806–5815. doi: 10.1158/1078-0432.CCR-12-0857 22912389
35. Chen WH, Minguez P, Lercher MJ, Bork P, (2012) OGEE: an online gene essentiality database. Nucleic Acids Res 40: D901–906. doi: 10.1093/nar/gkr986 22075992
36. Marusyk A, Almendro V, Polyak K, (2012) Intra-tumour heterogeneity: a looking glass for cancer? Nat Rev Cancer 12: 323–334. doi: 10.1038/nrc3261 22513401
37. Croce CM, (2008) Oncogenes and cancer. N Engl J Med 358: 502–511. doi: 10.1056/NEJMra072367 18234754
38. Lee EY, Muller WJ, (2010) Oncogenes and tumor suppressor genes. Cold Spring Harb Perspect Biol 2: a003236. doi: 10.1101/cshperspect.a003236 20719876
39. Abbas T, Dutta A, (2009) p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9: 400–414. doi: 10.1038/nrc2657 19440234
40. Berx G, van Roy F, (2009) Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb Perspect Biol 1: a003129. doi: 10.1101/cshperspect.a003129 20457567
41. Berndt A, Cario CL, Silva KA, Kennedy VE, Harrison DE, et al. (2011) Identification of fat4 and tsc22d1 as novel candidate genes for spontaneous pulmonary adenomas. Cancer Res 71: 5779–5791. doi: 10.1158/0008-5472.CAN-11-1418 21764761
42. Zang ZJ, Cutcutache I, Poon SL, Zhang SL, McPherson JR, et al. (2012) Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes. Nat Genet 44: 570–574. doi: 10.1038/ng.2246 22484628
43. Qi C, Zhu YT, Hu L, Zhu YJ, (2009) Identification of Fat4 as a candidate tumor suppressor gene in breast cancers. Int J Cancer 124: 793–798. doi: 10.1002/ijc.23775 19048595
44. Doherty JA, Rossing MA, Cushing-Haugen KL, Chen C, Van Den Berg DJ, et al. (2010) ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study. Cancer Epidemiol Biomarkers Prev 19: 245–250. doi: 10.1158/1055-9965.EPI-09-0729 20056644
45. Shankar J, Messenberg A, Chan J, Underhill TM, Foster LJ, et al. (2010) Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells. Cancer Res 70: 3780–3790. doi: 10.1158/0008-5472.CAN-09-4439 20388789
46. Dumitru CA, Bankfalvi A, Gu X, Zeidler R, Brandau S, et al. (2012) AHNAK and inflammatory markers predict poor survival in laryngeal carcinoma. PLoS One 8: e56420.
47. Chong IW, Chang MY, Chang HC, Yu YP, Sheu CC, et al. (2006) Great potential of a panel of multiple hMTH1, SPD, ITGA11 and COL11A1 markers for diagnosis of patients with non-small cell lung cancer. Oncol Rep 16: 981–988. 17016581
48. Kim H, Watkinson J, Varadan V, Anastassiou D, (2010) Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1. BMC Med Genomics 3: 51. doi: 10.1186/1755-8794-3-51 21047417
49. Wu YH, Chang TH, Huang YF, Huang HD, Chou CY, (2013) COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer. Oncogene 33: 3432–3440. doi: 10.1038/onc.2013.307 23934190
50. Kang CY, Wang J, Axell-House D, Soni P, Chu ML, et al. (2014) Clinical Significance of Serum COL6A3 in Pancreatic Ductal Adenocarcinoma. J Gastrointest Surg 18: 7–15. doi: 10.1007/s11605-013-2326-y 24002763
51. Arafat H, Lazar M, Salem K, Chipitsyna G, Gong Q, et al. (2011) Tumor-specific expression and alternative splicing of the COL6A3 gene in pancreatic cancer. Surgery 150: 306–315. doi: 10.1016/j.surg.2011.05.011 21719059
52. Jager N, Schlesner M, Jones DT, Raffel S, Mallm JP, et al. (2013) Hypermutation of the inactive X chromosome is a frequent event in cancer. Cell 155: 567–581. doi: 10.1016/j.cell.2013.09.042 24139898
53. Jones DT, Jager N, Kool M, Zichner T, Hutter B, et al. (2012) Dissecting the genomic complexity underlying medulloblastoma. Nature 488: 100–105. doi: 10.1038/nature11284 22832583
54. Losada A, (2014) Cohesin in cancer: chromosome segregation and beyond. Nat Rev Cancer 14: 389–393. doi: 10.1038/nrc3743 24854081
55. Solomon DA, Kim T, Diaz-Martinez LA, Fair J, Elkahloun AG, et al. (2011) Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science 333: 1039–1043. doi: 10.1126/science.1203619 21852505
56. Tamborero D, Gonzalez-Perez A, Lopez-Bigas N, (2013) OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes. Bioinformatics 29: 2238–2244. doi: 10.1093/bioinformatics/btt395 23884480
57. Han JD, Bertin N, Hao T, Goldberg DS, Berriz GF, et al. (2004) Evidence for dynamically organized modularity in the yeast protein-protein interaction network. Nature 430: 88–93. 15190252
58. Navin N, Kendall J, Troge J, Andrews P, Rodgers L, et al. (2011) Tumour evolution inferred by single-cell sequencing. Nature 472: 90–94. doi: 10.1038/nature09807 21399628
59. Levine JH, Lin Y, Elowitz MB, (2013) Functional roles of pulsing in genetic circuits. Science 342: 1193–1200. doi: 10.1126/science.1239999 24311681
60. Karr JR, Sanghvi JC, Macklin DN, Gutschow MV, Jacobs JM, et al. (2012) A whole-cell computational model predicts phenotype from genotype. Cell 150: 389–401. doi: 10.1016/j.cell.2012.05.044 22817898
61. Shapiro E, Biezuner T, Linnarsson S, (2013) Single-cell sequencing-based technologies will revolutionize whole-organism science. Nat Rev Genet 14: 618–630. doi: 10.1038/nrg3542 23897237
62. Costanzo M, Baryshnikova A, Bellay J, Kim Y, Spear ED, et al. (2010) The genetic landscape of a cell. Science 327: 425–431. doi: 10.1126/science.1180823 20093466
63. Sandhu KS, Li G, Poh HM, Quek YL, Sia YY, et al. (2012) Large-scale functional organization of long-range chromatin interaction networks. Cell Rep 2: 1207–1219. doi: 10.1016/j.celrep.2012.09.022 23103170
64. Leiserson MD, Vandin F, Wu HT, Dobson JR, Eldridge JV, et al. (2015) Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes. Nat Genet 47: 106–114. doi: 10.1038/ng.3168 25501392
65. Breuer K, Foroushani AK, Laird MR, Chen C, Sribnaia A, et al. (2013) InnateDB: systems biology of innate immunity and beyond—recent updates and continuing curation. Nucleic Acids Res 41: D1228–1233. doi: 10.1093/nar/gks1147 23180781
66. Cowley MJ, Pinese M, Kassahn KS, Waddell N, Pearson JV, et al. (2012) PINA v2.0: mining interactome modules. Nucleic Acids Res 40: D862–865. doi: 10.1093/nar/gkr967 22067443
67. Zhu Y, Qiu P, Ji Y, (2014) TCGA-assembler: open-source software for retrieving and processing TCGA data. Nat Methods 11: 599–600. doi: 10.1038/nmeth.2956 24874569
68. Hofree M, Shen JP, Carter H, Gross A, Ideker T, (2013) Network-based stratification of tumor mutations. Nat Methods 10: 1108–1115. doi: 10.1038/nmeth.2651 24037242
69. Vanunu O, Magger O, Ruppin E, Shlomi T, Sharan R, (2010) Associating Genes and Protein Complexes with Disease via Network Propagation. PLoS Computat Biol 6: e1000641.
70. Simini F, Gonzalez MC, Maritan A, Barabasi AL, (2012) A universal model for mobility and migration patterns. Nature 484: 96–100. doi: 10.1038/nature10856 22367540
71. Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, et al. (2011) COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 39: D945–950. doi: 10.1093/nar/gkq929 20952405
72. Higgins ME, Claremont M, Major JE, Sander C, Lash AE, (2007) CancerGenes: a gene selection resource for cancer genome projects. Nucleic Acids Res 35: D721–726. 17088289
73. Zhao M, Sun J, Zhao Z, (2013) TSGene: a web resource for tumor suppressor genes. Nucleic Acids Res 41: D970–976. doi: 10.1093/nar/gks937 23066107